Novo CEO pressed by Senate to chop rates of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would take into consideration new talks with insurers in regards to the listing selling prices of Wegovy and copyright if they pledge to keep the medicines on https://arthurehggh.isblog.net/everything-about-healthcare-news-47894257